Hamilton Morris interviews Vyvanse inventor Dr. Robert Oberlender
Dr. Robert Oberlender discusses his early career as a chemist within Dr. David Nichols' lab, emphasizing how foundational research efforts often relied on the collective contributions of many chemists over several decades, rather than being the work of a single individual. This dialogue highlights the rigorous, iterative nature of psychedelic chemistry and drug discovery where failure in one pathway often provides essential insights for future breakthroughs. Specific chemical challenges are explored, such as stereochemistry and the importance of specific chemical positions on phenethylamine molecules. The conversation also touches upon the evolution of drug development, moving from early self-experimentation to more modern, rigorous models of drug evaluation. The discussion underscores how historical curiosity, driven by passionate researchers, laid the groundwork for medical advancements and the pharmacological study of consciousness.
These entries start auto-generated and improve with human input. Your contributions help!
Published Aug 19, 2022 · Added Mar 31, 2026